EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

164 hedge funds and large institutions have $633M invested in Eagle Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-4
Holders Change %
-2.38%
% of All Funds
3.37%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
18
Increased
55
Reduced
68
Closed
22
Calls
$983K
Puts
$388K
Net Calls
+$595K
Net Calls Change
+$3.39M
Name Holding Trade Value Shares
Change
Shares
Change %
SGAM
176
Smith Group Asset Management
Texas
-$63K -1,372 Closed
FC
177
FORA Capital
Florida
-$44K -956 Closed
ClearBridge Investments
178
ClearBridge Investments
New York
-$27K -580 Closed
KBC Group
179
KBC Group
Belgium
-$23K -504 Closed
NFG
180
Next Financial Group
Texas
-$16K -358 Closed
PHK
181
Point72 Hong Kong
Hong Kong
-$9K -186 Closed
WAP
182
Wealthcare Advisory Partners
Pennsylvania
-$2K -45 Closed
CFGS
183
Concourse Financial Group Securities
Alabama
-$2K -40 Closed